Inflammatory Markers in Hyperlipidemia: From Experimental Models to Clinical Practice

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|37|4132-4146

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.37, 2011-12, pp. : 4132-4146

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Inflammatory Markers in Hyperlipidemia: Clinical Implications

By  

Current Medicinal Chemistry, Vol. 22, Iss. 23, 2015-01 ,pp. : 2727-2743

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiac Consequences of Anti-Inflammatory Drugs in Experimental Models

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 12, Iss. 1, 2013-03 ,pp. : 24-35

Bentham Science Publishers

Access to resources Recommend Favorite

Experimental hyperlipidemia prevents the protective effect of ischemic preconditioning on the contractility and responsiveness to phenylephrine of rat-isolated stunned papillary muscle - retrospective clinical evidence of preconditioning

By Kocic I.   Konstanski Z.x.   Kaminski M.   Dworakowska D.   Dworakowski R.x.  

General Pharmacology, Vol. 33, Iss. 3, 1999-09 ,pp. : 213-219

Elsevier

Access to resources Recommend Favorite

From the Editor: Frustrations in clinical practice

By Watkins Peter  

Clinical Medicine, Vol. 5, Iss. 5, 2005-09 ,pp. : 429-430

Royal College Of Physicians

Access to resources Recommend Favorite

Effect of polyherbal formulation on experimental models of inflammatory bowel diseases

By Jagtap A.G.   Shirke S.S.   Phadke A.S.  

Journal of Ethnopharmacology, Vol. 90, Iss. 2, 2004-02 ,pp. : 195-204

Elsevier

Access to resources Recommend Favorite